News & Updates
Filter by Specialty:
Add-on amantadine lessens “off” episodes in Parkinson’s disease
A delayed release/extended release (DR/ER) formulation of amantadine can help reduce breakthrough symptoms in Parkinson’s disease patients when the effect of levodopa therapy wears off, as shown in a recent study.
Add-on amantadine lessens “off” episodes in Parkinson’s disease
06 Apr 2022
Deep learning predicts Alzheimer’s disease up to 4 years before onset
A graph convolutional and recurrent neural network model can identify patients who are likely to develop Alzheimer’s disease at around 80 percent accuracy, according to a recent Singapore study.
Deep learning predicts Alzheimer’s disease up to 4 years before onset
04 Apr 2022
Healthy lifestyle behaviours protect against dementia in AF patients
Patients with new-onset atrial fibrillation (AF) who practice a healthy lifestyle appear to be at lower risk of dementia, a study has shown.
Healthy lifestyle behaviours protect against dementia in AF patients
02 Apr 2022
Cinnamon plus aspirin: A recipe for lowering short-term recurrent stroke risk
In the treatment of patients with mild ischaemic stroke or transient ischaemic attack (TIA), the combination of cinnamon and aspirin outperforms aspirin alone at reducing the risk of 90-day recurrent stroke, as shown in a study.
Cinnamon plus aspirin: A recipe for lowering short-term recurrent stroke risk
01 Apr 2022
Antiseizure effect of cannabidiol seen within 2 weeks of treatment
In the treatment of patients with drug-resistant epilepsy associated with tuberous sclerosis complex, the antiseizure effect of cannabidiol occurs within 6–10 days, according to the results of a phase III trial. Adverse events also emerge during the first 2 weeks of the titration period, and majority of these are resolved during the 16-week treatment period.